Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes

doi:10.1111/dom.15791

. 2024 Oct;26(10):4767-4771.

doi: 10.1111/dom.15791. Epub 2024 Jul 18.

Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes

Claudia Piona¹, Stefano Passanisi², Bruno Bombaci², Marco Marigliano¹, Fortunato Lombardo², Valentina Mancioppi¹, Anita Morandi¹, Claudio Maffeis¹, Giuseppina Salzano²; ISPED Diabetes Study Group

Collaborators, Affiliations

Collaborators

ISPED Diabetes Study Group:
Caterina Grosso, Valentino Cherubini, Valentina Tiberi, Elvira Piccinno, Clara Zecchino, Giulio Maltoni, Stefano Zucchini, Petra Reinstadler, Barbara Felappi, Elena Prandi, Carlo Ripoli, Maria Rossella Ricciardi, Filomena Stamati, Donatella Lo Presti, Giuseppe Costanza, Giulia Pezzino, Sara Monti, Rosaria De Marco, Elena Calzi, Nicola Minuto, Marta Bassi, Anna Bratta, Giordano Spacco, Maurizio Delvecchio, Riccardo Bonfanti, Andrea Rigamonti, Giulio Frontino, Francesco Scialabba, Chiara Mameli, Barbara Predieri, Dario Iafusco, Angela Zanfardino, Enza Mozzillo, Francesco Rosanio, Francesca Di Candia, Ivana Rabbone, Erica Pozzi, Francesca Cardella, Rosalia Roppolo, Vanna Graziani, Sara Dal Bo, Riccardo Schiaffini, Davide Tinti, Roberto Franceschi, Claudia Arnaldi, Davide Tosini, Chiara Riso

Affiliations

¹ Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital, Verona, Italy.
² Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Messina, Italy.

PMID: 39021339
DOI: 10.1111/dom.15791

Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes

Claudia Piona et al. Diabetes Obes Metab. 2024 Oct.

. 2024 Oct;26(10):4767-4771.

doi: 10.1111/dom.15791. Epub 2024 Jul 18.

Authors

Collaborators

ISPED Diabetes Study Group:
Caterina Grosso, Valentino Cherubini, Valentina Tiberi, Elvira Piccinno, Clara Zecchino, Giulio Maltoni, Stefano Zucchini, Petra Reinstadler, Barbara Felappi, Elena Prandi, Carlo Ripoli, Maria Rossella Ricciardi, Filomena Stamati, Donatella Lo Presti, Giuseppe Costanza, Giulia Pezzino, Sara Monti, Rosaria De Marco, Elena Calzi, Nicola Minuto, Marta Bassi, Anna Bratta, Giordano Spacco, Maurizio Delvecchio, Riccardo Bonfanti, Andrea Rigamonti, Giulio Frontino, Francesco Scialabba, Chiara Mameli, Barbara Predieri, Dario Iafusco, Angela Zanfardino, Enza Mozzillo, Francesco Rosanio, Francesca Di Candia, Ivana Rabbone, Erica Pozzi, Francesca Cardella, Rosalia Roppolo, Vanna Graziani, Sara Dal Bo, Riccardo Schiaffini, Davide Tinti, Roberto Franceschi, Claudia Arnaldi, Davide Tosini, Chiara Riso

Affiliations

¹ Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital, Verona, Italy.
² Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, Messina, Italy.

PMID: 39021339
DOI: 10.1111/dom.15791

No abstract available

Keywords: CGM metrics; Medtronic Minimed™ 780G; Tandem t:Slim X2™ Control IQ; paediatrics; target.

PubMed Disclaimer

Cited by

A Review of Real-World Evidence About the Use of Automated Insulin Delivery Systems in People With Type 1 Diabetes.
Gera S, Iyer J, Meighan S, March CA, Marks BE. Gera S, et al. Endocr Pract. 2025 Jun 10:S1530-891X(25)00917-6. doi: 10.1016/j.eprac.2025.06.004. Online ahead of print. Endocr Pract. 2025. PMID: 40505729 Review.
Real-world evaluation of safety and efficacy of AHCL systems in young children with type 1 diabetes: a 1-year assessment.
Franzone D, Spacco G, Piano A, Siri G, Tantari G, d'Annunzio G, Calevo MG, Maghnie M, Minuto N, Bassi M. Franzone D, et al. Front Endocrinol (Lausanne). 2025 Jun 26;16:1590964. doi: 10.3389/fendo.2025.1590964. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40642512 Free PMC article.
Long-Term Performance of Two Systems for Automated Insulin Delivery in Adults With Type 1 Diabetes: An Observational Study.
Fisker S, Christensen M, Bach E, Bibby BM, Hansen KW. Fisker S, et al. Endocrinol Diabetes Metab. 2025 May;8(3):e70043. doi: 10.1002/edm2.70043. Endocrinol Diabetes Metab. 2025. PMID: 40198839 Free PMC article.
Enhanced Metabolic Control in a Pediatric Population with Type 1 Diabetes Mellitus Using Hybrid Closed-Loop and Predictive Low-Glucose Suspend Insulin Pump Treatments.
Bojoga I, Ioacara S, Malinici E, Chiper V, Georgescu O, Sirbu AE, Fica S. Bojoga I, et al. Pediatr Rep. 2024 Dec 14;16(4):1188-1199. doi: 10.3390/pediatric16040100. Pediatr Rep. 2024. PMID: 39728741 Free PMC article.
Glucose alarms approach with flash glucose monitoring system: a narrative review of clinical benefits.
Krakauer M, Travassos S, Rodacki M, Gabbay MAL, Vianna AGD, Scharf M, Lamounier RN, Franco DR, Araújo LR, Calliari LE. Krakauer M, et al. Diabetol Metab Syndr. 2025 Jul 16;17(1):276. doi: 10.1186/s13098-025-01797-3. Diabetol Metab Syndr. 2025. PMID: 40671052 Free PMC article. Review.

See all "Cited by" articles

References

REFERENCES

1. Jendle J, Reznik Y. Use of insulin pumps and closed‐loop systems among people living with diabetes: a narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers. Diabetes Obes Metab. 2023;25(Suppl 2):21‐32.
1. Phillip M, Nimri R, Bergenstal RM, et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev. 2023;44(2):254‐280.
1. Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11(1):42‐57.
1. Akturk HK, Battelino T, Castañeda J, Arrieta A, van den Heuvel T, Cohen O. Future of time‐in‐range goals in the era of advanced hybrid closed‐loop automated insulin delivery systems. Diabetes Technol Ther. 2024;26(S3):102‐106.
1. Libman I, Haynes A, Lyons S, et al. ISPAD clinical practice consensus guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1160‐1174.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

[1] Jendle J, Reznik Y. Use of insulin pumps and closed‐loop systems among people living with diabetes: a narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers. Diabetes Obes Metab. 2023;25(Suppl 2):21‐32.

[2] Jendle J, Reznik Y. Use of insulin pumps and closed‐loop systems among people living with diabetes: a narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers. Diabetes Obes Metab. 2023;25(Suppl 2):21‐32.

[3] Phillip M, Nimri R, Bergenstal RM, et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev. 2023;44(2):254‐280.

[4] Phillip M, Nimri R, Bergenstal RM, et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev. 2023;44(2):254‐280.

[5] Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11(1):42‐57.

[6] Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11(1):42‐57.

[7] Akturk HK, Battelino T, Castañeda J, Arrieta A, van den Heuvel T, Cohen O. Future of time‐in‐range goals in the era of advanced hybrid closed‐loop automated insulin delivery systems. Diabetes Technol Ther. 2024;26(S3):102‐106.

[8] Akturk HK, Battelino T, Castañeda J, Arrieta A, van den Heuvel T, Cohen O. Future of time‐in‐range goals in the era of advanced hybrid closed‐loop automated insulin delivery systems. Diabetes Technol Ther. 2024;26(S3):102‐106.

[9] Libman I, Haynes A, Lyons S, et al. ISPAD clinical practice consensus guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1160‐1174.

[10] Libman I, Haynes A, Lyons S, et al. ISPAD clinical practice consensus guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022;23(8):1160‐1174.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes

Collaborators

Affiliations

Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes

Authors

Collaborators

Affiliations

Similar articles

Cited by

References

REFERENCES

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Research Materials

Similar articles

Cited by

References

REFERENCES

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Medical

Research Materials